Report Categories
View AllRecent Articles
View All
Is Evgo Evgo Stock Near Resistance Price At 1.77 Up 3.80 20260406
Is Dolly Varden Dvs Stock Showing Strength Price At 2.74 Down 6.48 20260406
Should I Buy Olaplex Holdings Olpx Stock In 2026 Olpx Q4 2025 Earnings Olaplex Holdings Inc. Tops Eps Estimates By Over 40 Percent 20260406 1
Nuveen New NXJ Flat at 1241 Consolidation Continues 20260519
Anthropics Mythos Sparks Cybersecurity Alarm Experts Warn Threat Is Not New
Elastic NV ESTC Q1 2026 Earnings EPS 073 Beats Estimates
Pasithea Therapeutics KTTA Q1 2026 Earnings 012 EPS Surges Past 046 Estimates
Inflation Pressures Widen Beyond Oil and Iran Housing Food and Services Show Price Acceleration
AIRelated Layoffs and Stock Performance A Nuanced Relationship
Cambridge Living Costs Push Employed Residents to Rely on Food Banks
ExBankers Command 25000 Per Day to Train Wall Street on AI
Paul Tudor Jones Says Kevin Warsh Would Face No Chance of Fed Rate Cuts
Borosil Glass Works Stock Surges 200 in a Year on Strong Revenue Growth
Chemomab Therapeutics Ltd CMMB Q1 2026 Earnings WiderThanExpected Loss Amid PreClinical Progress
DFLI Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain
DocGo DCGO Q1 2026 Earnings EPS Misses by 3655 as Stock Rises 479
VNOM Q1 2026 Earnings Strong Earnings Beat Highlights Operational Execution
NBHC Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue
MIND CTI Ltd MNDO Edges Higher Amid Consolidation Key Levels to Watch
CP Shares Edge Lower Amid Sector Headwinds
BIOX Edges Higher as Shares Test Resistance in Narrow Range
Simon Property Group SPG Holds Steady Near MidRange as Retail REIT Sector Waits for Catalysts
MITN Slips 05 Amid FixedIncome Volatility Technical Levels Hold
ZBIO Q1 2026 Earnings Narrower Loss Surprises Analysts as Pipeline Progress Continues
APRE Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline
VERA Q1 2026 Earnings WiderThanExpected Loss Masks Progress in Pipeline
EXLS Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Pending
IRS Q1 2026 Earnings Substantial Net Loss Amid Argentine Economic Headwinds
Lantern Pharma LTRN Q1 2026 Earnings EPS Beats Estimates by 183 Despite Absence of Revenue